Skip to main content

MoneyWorks4Me

Clarification sought from Aurobindo Pharma

22 Jul 2015 Evaluate

The Exchange has sought clarification from Aurobindo Pharma with reference to the news article in The Economic Times, on July 22, 2015 captioned ‘Aurobindo Pharma Comes Under US FDA Lens’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..